Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05797441 · ClinicalTrials.gov registry record · NA

Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

A NA study of Post Traumatic Stress Disorder and PTSD, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
80
Enrollment target
8
Study locations

NCT05797441: Active NA study of Post Traumatic Stress Disorder and PTSD, sponsored by VA Office of Research and Development.

NCT05797441 is a NA study of Post Traumatic Stress Disorder and PTSD that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 80 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (88% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05797441, a NA study of Post Traumatic Stress Disorder and PTSD, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
8
Study locations

Study Summary

Patients who complete prolonged exposure and cognitive processing therapy, the treatments for posttraumatic stress disorder (PTSD) with the most empirical support, continue to express a need for mental health treatment. A therapist-assisted self-management program for patients who have completed one of these two treatments and achieved symptom improvement has the potential to meet patients' stated treatment needs, maintain or build upon their PTSD symptom reductions, increase their confidence in managing their symptoms, and reduce the number of mental health appointments that they need to attend. Further, reducing the number if mental health sessions attended by completers of these time and resource intensive psychotherapies will increase the likelihood that their implementation in regular-practice clinics will be maintained.

Primary Outcome

PTSD Symptom Severity - Self-Reported; Range = 0-80; higher scores = more severe symptoms

Interventions

  • OTHER Treatment As Usual
  • BEHAVIORAL EMPOWER

Study Locations (8)

Illinois

  • Jesse Brown VA Medical Center, Chicago, IL - Chicago
  • Edward Hines Jr. VA Hospital, Hines, IL - Hines

California

  • VA Greater Los Angeles Healthcare System, Sepulveda, CA - Sepulveda

Florida

  • James A. Haley Veterans' Hospital, Tampa, FL - Tampa

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

North Carolina

  • Durham VA Medical Center, Durham, NC - Durham

Ohio

  • Cincinnati VA Medical Center, Cincinnati, OH - Cincinnati

South Carolina

  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC - Columbia

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-10-16
Est. Completion 2026-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the registry record for NCT05797441 still lists

NCT05797441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.

NCT05797441 lists 8 locations in 7 states (Illinois, California, Florida).

Frequently Asked Questions

What is clinical trial NCT05797441 about?

NCT05797441 is a clinical study titled "Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy". Patients who complete prolonged exposure and cognitive processing therapy, the treatments for posttraumatic stress disorder (PTSD) with the most empirical support, continue to express a need for mental health treatment. A therapist-assisted self-management program for patients who have completed one...

What is the current status of trial NCT05797441?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-10-16. Estimated completion is 2026-03-31.

What conditions does trial NCT05797441 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, PTSD.

What interventions are being tested in trial NCT05797441?

The interventions under investigation include: Treatment As Usual (OTHER), EMPOWER (BEHAVIORAL).

Who is sponsoring clinical trial NCT05797441?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05797441 being conducted?

This trial has 8 study locations across California, Florida, Illinois, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05797441's enrollment target sits among peer trials

80 135th of 262 higher than 121 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05797441, the US trial registry maintained by the National Library of Medicine. NCT05797441 (small enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.